Bruce Frederick Scharschmidt insider trades: Hyperion Therapeutics (HPTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Bruce reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 27, 2015 | HPTX | ↓ Sell | 24,996 | $29.79 | $745K | By The Bruce Frederick Scharschimdt and | Mar 3, 2015 (4d) |
| Feb 27, 2015 | HPTX | ↓ Sell | 4,804 | $30.43 | $146K | Crawford Family Trust dated October 9, 2 | Mar 3, 2015 (4d) |
| Jul 2, 2014 | HPTX | ↓ Sell | 200 | $28.00 | $6K | By The Bruce Frederick Scharschmidt and | Jul 3, 2014 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Bruce Frederick Scharschmidt's insider trades
Bruce Frederick Scharschmidt is SVP & Chief Medical Officer at Hyperion Therapeutics (HPTX). Since Jul 2, 2014, Bruce has reported no open-market purchases and 3 sales worth $896K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (10 filings), grants and awards (3 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HPTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.